Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Tentative Proposal of Optimal Timing of Kasai Operation for Biliary Atresia Based on Fibroscan Results

간섬유화스캔을 이용한 선천성 담도 폐쇄증의 최적 수술시기 시험적 제안

  • Lee, Hwa-Young (Department of Pediatrics, Yonsei University College of Medicine) ;
  • Park, Young-A (Department of Pediatrics, Yonsei University College of Medicine) ;
  • Han, Seok-Joo (Department of Surgery, Yonsei University College of Medicine) ;
  • Koh, Hong (Department of Pediatrics, Yonsei University College of Medicine)
  • 이화영 (연세대학교 의과대학 소아과학교실) ;
  • 박영아 (연세대학교 의과대학 소아과학교실) ;
  • 한석주 (연세대학교 의과대학 외과학교실) ;
  • 고홍 (연세대학교 의과대학 소아과학교실)
  • Received : 2010.08.13
  • Accepted : 2010.09.10
  • Published : 2011.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Based on previous research findings, it is well-known that the timing of surgery is generally considered the most important prognostic factor for a Kasai portoenterostomy, the primary treatment for biliary atresia. This research aimed to identify the optimal timing of a Kasai portoenterostomy and to verify if the proposed optimal timing corresponds to previous studies. All patients were classified by the timing of surgery, and pre- and post-operative fibrotic changes of the liver were measured with the elasticity value from fibroscans. Methods: The stiffness scores of the pre- and post-operative fibroscans in 34 patients who were treated by Kasai portoenterostomy from October 2007 to September 2010 in Severance children's hospital were reviewed. Results: The earlier the patients were treated by Kasai portoenterostomy, the lower the fibroscan scores. When the patients were treated prior to the 8th week, the post-operative scores of the fibroscans were significantly better than those patients who were treated after the 8th week, and some even recovered partially. Moreover, when operated before the 8th week, the differences between each pre- and postoperative fibroscan score also showed statistical relevance (p=0.0002). Conclusion: The earlier the patient was treated by Kasai portoenterostomy, the less liver fibrosis that developed, the lower the level of post-operative fibrosis, and the less the degree of fibrotic progress before and after the operation. Thus, this research proposal reconfirms once more that the 8th week is the optimal timing for a Kasai portoenterostomy.

목 적: 선천성 담도폐쇄증의 일차적 치료로 알려진 Kasai 수술에서의 가장 중요한 예후 인자로 수술 시기가 중요하다는 것은 기존의 연구 결과들을 통해 잘 알려져 있다. 본 연구에서는 선천성 담도 폐쇄증 환아들을 수술 시기별로 분류하고 간섬유화 스캔을 수술 전후에 시행하여 얻어진 간탄성률값을 이용하여 수술 전후의 간 섬유화 변화를 비교함으로서 본 연구에서 도출된 최적의 수술시기가 기존의 연구와 일치하는지 재확인 하고자 한다. 방 법: 2007년 10월부터 2010년 7월까지 단일 기관에서 Kasai 수술을 시행 받은 환자 중, 수술 전후로 간섬유화 스캔을 시행한 환자 34명을 대상으로 수술 시기별 간탄성률 결과값을 비교하였다. 결 과: 환자군의 수술 시기가 빠를수록 수술 전과 후 모두에서 간탄성률 결과값은 좋았고, 특히 8주 이전에 수술을 시행 받은 경우 그 이상에서 수술을 받은 환자군보다 수술 후의 간섬유화가 적게 진행되었고 일부에서는 회복되었다. 또한 8주 수술 전후의 각 탄성률 간의 차이값 또한 통계적으로 유의하였다. 결 론: Kasai 수술의 시기가 이를수록 수술 전 간 섬유화가 적고, 적어도 8주 이전에서 Kasai 수술을 시행하였을 때 수술 이후의 간섬유화가 양호하였으며 수술전후의 간섬유화 진행 정도가 크지 않았다. 따라서 본 연구에서는 간섬유화스캔을 바탕으로 적어도 8주 미만의 연령이 Kasai 수술을 시행 받기에 최적의 시기임을 재확인하였다.

Keywords

References

  1. Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet 2009;374:1704-13. https://doi.org/10.1016/S0140-6736(09)60946-6
  2. Hays DM, Snyder WH Jr. Life-span in untreated biliary atresia. Surgery 1963;54:373-5.
  3. Kasai M, Suzuki S. A new operation for "non correctable" biliary atresia: hepatic portoenterostomy. Shujitsu 1959;13:733-9.
  4. Karrer FM, Lilly JR, Stewart BA, Hall RJ. Biliary atresia registry, 1976 to 1989. J Pediatr Surg 1990;25:1076-80; discussion 81. https://doi.org/10.1016/0022-3468(90)90222-U
  5. Houwen RH, Zwierstra RP, Severijnen RS, Bouquet J, Madern G, Vos A, et al. Prognosis of extrahepatic biliary atresia. Arch Dis Child 1989;64:214-8. https://doi.org/10.1136/adc.64.2.214
  6. Ohi R, Nio M, Chiba T, Endo N, Goto M, Ibrahim M. Long-term follow-up after surgery for patients with biliary atresia. J Pediatr Surg 1990;25:442-5. https://doi.org/10.1016/0022-3468(90)90390-U
  7. Ohi R. Biliary atresia. A surgical perspective. Clin Liver Dis 2000;4:779-804. https://doi.org/10.1016/S1089-3261(05)70141-0
  8. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-50. https://doi.org/10.1053/j.gastro.2004.11.018
  9. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007;56:968. https://doi.org/10.1136/gut.2006.111302
  10. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-13. https://doi.org/10.1016/j.ultrasmedbio.2003.07.001
  11. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Ledinghen V, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009;29:242-7. https://doi.org/10.1111/j.1478-3231.2008.01802.x
  12. Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouilleres O, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006;43:1118-24. https://doi.org/10.1002/hep.21151
  13. Gomez-Dominguez E, Mendoza J, Garcia-Buey L, Trapero M, Gisbert JP, Jones EA, et al. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. Aliment Pharmacol Ther 2008;27:441-7.
  14. Chang HK, Park YJ, Koh H, Kim SM, Chung KS, Oh JT, et al. Hepatic fibrosis scan for liver stiffness score measurement: a useful preendoscopic screening test for the detection of varices in postoperative patients with biliary atresia. J Pediatr Gastroenterol Nutr 2009;49:323-8. https://doi.org/10.1097/MPG.0b013e31819de7ba
  15. McKiernan PJ. Neonatal cholestasis. Semin Neonatol 2002;7:153-65. https://doi.org/10.1053/siny.2002.0103
  16. Sokol RJ, Shepherd RW, Superina R, Bezerra JA, Robuck P, Hoofnagle JH. Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology 2007;46:566-81. https://doi.org/10.1002/hep.21790
  17. Sokol RJ, Stall C. Anthropometric evaluation of children with chronic liver disease. Am J Clin Nutr 1990;52:203-8. https://doi.org/10.1093/ajcn/52.2.203
  18. Davenport M, De Ville de Goyet J, Stringer MD, Mieli-Vergani G, Kelly DA, McClean P, et al. Seamless management of biliary atresia in England and Wales (1999-2002). Lancet 2004;363:1354-7. https://doi.org/10.1016/S0140-6736(04)16045-5
  19. Jeong H, Choi BH, Hwang S, Kim KM, Kim SC, Park KM, et al. Factors influencing the early outcome following liver transplantation for biliary atresia. Korean J Gastroenterol 2000;35:212-8.
  20. Altman RP, Lilly JR, Greenfeld J, Weinberg A, van Leeuwen K, Flanigan L. A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg 1997;226:348-53; discussion 53-5. https://doi.org/10.1097/00000658-199709000-00014
  21. Chiba T. Indication of Kasai's operation for biliary atresia: for early decision of liver transplantation. Nippon Geka Hokan 1988;57:261-6.
  22. Chardot C, Carton M, Spire-Bendelac N, Le Pommelet C, Golmard J, Reding R, et al. Is the Kasai operation still indicated in children older than 3 months diagnosed with biliary atresia? J Pediatr 2001;138:224-8. https://doi.org/10.1067/mpd.2001.111276
  23. A-Kader HH, Balisteri WF. Cholestasis. In: Behrman RE, Kliegman RM, Jenson HB, editors. Nelson textbook of pediatrics. 17th ed. Philadelphia: Sunders, 2004:1314-9.
  24. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000;32: 477-81. https://doi.org/10.1053/jhep.2000.16602
  25. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003;39:239-44. https://doi.org/10.1016/S0168-8278(03)00191-0
  26. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986;2:165-73. https://doi.org/10.1016/S0168-8278(86)80075-7
  27. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986;1:523-5.
  28. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;55:403-8. https://doi.org/10.1136/gut.2005.069153
  29. Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007;45:1290-7. https://doi.org/10.1002/hep.21665
  30. de Ledinghen V, Vergniol J. Transient elastography (FibroScan). Gastroenterol Clin Biol 2008;32:58-67. https://doi.org/10.1016/S0399-8320(08)73994-0
  31. Kettaneh A, Marcellin P, Douvin C, Poupon R, Ziol M, Beaugrand M, et al. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol 2007;46:628-34. https://doi.org/10.1016/j.jhep.2006.11.010
  32. de Ledinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 2007;45:443-50. https://doi.org/10.1097/MPG.0b013e31812e56ff
  33. Lee H, Kang J, Kim KM, Jang JY, Jang SJ, Yu E. The Clinicopathological Parameters for Making the Differential Diagnosis of Neonatal Cholestasis. [Journal Article MH - Infant MH - Male MH - Female MH - Infant, Newborn MH - Humans]. Korean J Pathol AID -10.4132/KoreanJPathol.2009.43.1.43 [doi] 2009;43:43-7.
  34. Kim SY, Seok JY, Han SJ, Koh H. Assessment of liver fibrosis and cirrhosis by aspartate aminotransferase-toplatelet ratio index in children with biliary atresia. J Pediatr Gastroenterol Nutr 2010;51:198-202. https://doi.org/10.1097/MPG.0b013e3181da1d98
  35. Weerasooriya VS, White FV, Shepherd RW. Hepatic fibrosis and survival in biliary atresia. J Pediatr 2004;144: 123-5. https://doi.org/10.1016/j.jpeds.2003.09.042